EFFECTS OF AGE ON THE PROTEIN-BINDING AND DISPOSITION OF PROPRANOLOL STEREOISOMERS

被引:34
|
作者
LALONDE, RL [1 ]
TENERO, DM [1 ]
BURLEW, BS [1 ]
HERRING, VL [1 ]
BOTTORFF, MB [1 ]
机构
[1] UNIV TENNESSEE,CTR HLTH SCI,DEPT MED,MEMPHIS,TN 38163
关键词
D O I
10.1038/clpt.1990.56
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Previous studies of the effects of age on the disposition of propranolol have produced variable results. We evaluated the stereoselective disposition and protein binding of propranolol enantiomers in 10 young (mean age, 28 years) and 10 older (mean age, 64 years) healthy subjects. After receiving racemic propranolol orally for 6 days, the oral clearances of d-propranolol and l-propranolol were lower by 13% and 17% in the older group compared to the young group, but these differences were not statistically significant. The older subjects had higher α1-acid glycoprotein concentrations (p < 0.05) and lower unbound fractions of l-propranolol (p < 0.05). After protein binding was accounted for, the unbound oral clearance of each enantiomer was similar in both groups. l-Propranolol was more highly protein bound than d-propranolol (p < 0.05) in both young and older subjects. The unbound oral clearance d l ratio was not different from unity in either group, indicating that the stereoselective differences in oral clearance were largely attributable to the stereoselective differences in protein binding. © 1990.
引用
收藏
页码:447 / 455
页数:9
相关论文
共 50 条
  • [1] STEREOSPECIFIC PROTEIN-BINDING OF PROPRANOLOL
    WEBSTER, WB
    PIEPER, JA
    DRUG INTELLIGENCE & CLINICAL PHARMACY, 1985, 19 (06): : 463 - 463
  • [2] PROTEIN-BINDING AND DISPOSITION OF LIGNOCAINE IN THE ELDERLY
    CUSACK, B
    OMALLEY, K
    LAVAN, J
    NOEL, J
    KELLY, JG
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1985, 29 (03) : 323 - 329
  • [3] CARBAMAZEPINE PROTEIN-BINDING AND DISPOSITION IN PREGNANCY
    YERBY, MS
    FRIEL, PN
    MILLER, DQ
    THERAPEUTIC DRUG MONITORING, 1985, 7 (03) : 269 - 273
  • [4] VALPROIC ACID DISPOSITION AND PROTEIN-BINDING IN PREGNANCY
    KOERNER, M
    YERBY, M
    FRIEL, P
    MCCORMICK, K
    THERAPEUTIC DRUG MONITORING, 1989, 11 (03) : 228 - 230
  • [5] INFLUENCE OF SURGERY ON PLASMA PROPRANOLOL LEVELS AND PROTEIN-BINDING
    FEELY, J
    FORREST, A
    GUNN, A
    HAMILTON, W
    STEVENSON, I
    CROOKS, J
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1980, 28 (06) : 759 - 764
  • [6] PROPRANOLOL ENANTIOMER PHARMACOKINETICS AND PROTEIN-BINDING IN BLACKS AND WHITES
    JOHNSON, JA
    BURLEW, BS
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1992, 51 (02) : 153 - 153
  • [7] DISPOSITION AND PROTEIN-BINDING OF VALPROIC ACID IN THE DEVELOPING RAT
    HABERER, LJ
    POLLACK, GM
    DRUG METABOLISM AND DISPOSITION, 1994, 22 (01) : 113 - 119
  • [8] PHENOBARBITAL - DISPOSITION INTO FETAL TISSUE AND THE INFLUENCE OF PROTEIN-BINDING
    MCCABE, DP
    FLYNN, EJ
    FEDERATION PROCEEDINGS, 1986, 45 (03) : 206 - 206
  • [9] ALTERED PROTEIN-BINDING OF PROPRANOLOL AND WARFARIN IN THYROID-DISORDERS
    FEELY, J
    CROOKS, J
    CLINICAL RESEARCH, 1980, 28 (02): : A235 - A235
  • [10] PHARMACOKINETIC DISPOSITION AND PROTEIN-BINDING OF FUROSEMIDE IN NEWBORN-INFANTS
    ARANDA, JV
    PEREZ, J
    SITAR, DS
    COLLINGE, J
    PORTUGUEZMALAVASI, A
    DUFFY, B
    DUPONT, C
    JOURNAL OF PEDIATRICS, 1978, 93 (03): : 507 - 511